Vårdprogram för barn och ungdomar med autismspektrumtillstånd

Leskovec, Thomas J. et al. 2008. Pharmacological Treatment Options for Autism Spectrum
Disorders in Children and Adoloscents. Harv Rev Psychiatry. March-april.
Levisohn, Paul M. 2007. The autism-epilepsy connection. Epilepsia. 48 (Suppl 9): 33-35.
Luby, Joan et al. 2006. Risperidone in Preschool Children with Autsitic Spectrum Disorders:
An Investigation of Safety and Efficacy. Journal of Child and Adolescent
Psychopharmacology. Vol.16, No. 5.
Matson, Johnny L., Dempsey, Timothy 2008. Autism Spectrum Disorders: Pharmacotherapy
for Challenging Behaviors. J Dev Phys Disabil. 20:175-191.
McCracken, James T. et al. 2002. Risperdone in Children with Autism and Serious Behavioral
Problems. The New England Journal of Medicine, Vol. 347, No 5.
McDougle, C.J., Stigler, K.A., Posey D.J. 2003. Treatment of Aggression in Children and
Adolescents with Autism and Conduct Disorder. J. Clin Psychiatry 64 (suppl 4).
McDougle, C.J. et al. 2008 Atypical Antipsychotics in Children and Adolescents with Autistic
and Other Pervasive Developmental Disorders. J. Clin Psychiatry 69 (suppl 4).
McDougle, C.J. et al. 2005. Risperidone for the Core Symtom Domains of Autism: Results
From the Study by the Autism Network of the Research Units om Pediatric
Psychopharmacology. Am J Psychiatry 162:6, June.
Mao, Alice R. 2008. Reaching Autism: From Basic Science to Clinical Intervention. American
Academy of Child & Adolescent Psychiatry, 55 th Annual Meeting.
Myers, Scott M., Johnson Chris P. 2007. Management of Children With Autism Spectrum
Disorders. Pediatrics. Vol. 120, No. 5, November.
Myers, Scott M. 2007. The status of pharmacotherapy for autism spectrum disorders. Expert
Opinion, Pharmacother.
Nydén, A.,Hjelmquist, E. Gillberg, C. 2000. Autism spectrum and attention - deficit disorders
in girls. Some neuropsychological aspects. European Child & Adolescent Psychiatry.
9:180-185.
Peake, Deirdre, Notghi, Lesley M., Philip, Sunny 2006. Management of epilepsy in children
with autism. Current Paediatrics.16, 489-494.
Pliszka, Steven R. et al. 2006. The Texas Children´s Medication Algorithm Project: Revision
of the Algorithm for Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder. J.Am.
Acad. Child Adolesc. Psychiatry. 45:6.
Owley, Thomas et al. 2005. An Open-Label Trial of Escitalopram in Pervasive Developmental
Disorders. J.Am. Acad. Child Adolesc. Psychiatry. 44:4.
Pérez, Juan Martos, González, Pedro M. Comi, Maria Llorente, Nieto, Carmen. 2007. New
Developments in Autism. The future is Today. Jessica Kingsley Publishers London and
Philadelphi.
Posey, David J. et al. 2006. The Use of Selective Serotonin Reuptake Inhibitors in Autism and
Related Disorders. Journal of Child and Adolescent Psychopharmacology. Vol.16. No 1/2.
Posey, David J., Stigler, K.A., Erickson, C.A., McDougle, C.J. 2008. Antipsychotics in the
treatment of autism. The Journal of Clinical Investigation. Vol. 118. No 1.
Posey, David J. et al. 2006. Open-Label Atomoxetine for Attention-Deficit/Hyperactivity
Disorder Symtoms Associated with High-Functioning Pervasive Developmental Disorders.
Journal of Child and Adolescent Psychopharmacology. Vol.16, No 5.
Posey, David J. and Research Units on Pediatric Psychopharmacology(RUPP) 2005. Autism
Network Participants. Randomized, Controlled, Crossover Trial of Methylphenidate in
Pervasive Developmental Disorders With Hyperactivity. Arch Gen Psychiatry. Vol. 62.
Quintana, Humberto et al. 1995. Use of Methylphenidate in the Treatment of Children with
Autistic Disorder. Journal of Autism and Developmental Disorder. Vol.25 No.3.
Richdale, Amanda L. 1999. Sleep problems in autism: prevalence, cause, and intervention.
Developmental Medicine & Child Neurology. 41.
70